What is Pfizer's u.s. — revenues:?

Pfizer (PFE) reported u.s. — revenues: of $8.73B in Q1 2026.

How has Pfizer's u.s. — revenues: changed year-over-year?

Pfizer's u.s. — revenues: increased by 4.3% year-over-year, from $8.37B to $8.73B.

What is the long-term trend for Pfizer's u.s. — revenues:?

Over 4 years (2021 to 2025), Pfizer's u.s. — revenues: has grown at a 5.7% compound annual growth rate (CAGR), from $29.75B to $37.08B.

Geographic · Revenues:

U.S. — Revenues:

Pfizer U.S. — Revenues: decreased by 4.3% to $8.73B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $8.37B to $8.73B. Over 4 years (FY 2021 to FY 2025), U.S. — Revenues: shows an upward trend with a 5.7% CAGR.

Analysis

StatementSegment

First reportedQ1 2016

Last reportedQ1 2026May 5, 2026

Rolls up toTotal Revenue

Metric ID: pfe_segment_u_s_revenues

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$7.52B	$7.02B	$7.68B	$8.92B	$11.22B	$13.85B	$9.33B	$8.71B	$6.46B	$8.06B	$4.91B	$9.51B	$7.89B	$12.06B	$9.22B	$8.37B	$8.89B	$10.69B	$9.12B	$8.73B
QoQ Change	—	-6.6%	+9.4%	+16.1%	+25.8%	+23.4%	-32.7%	-6.6%	-25.9%	+24.9%	-39.1%	+93.7%	-17.0%	+52.9%	-23.6%	-9.2%	+6.2%	+20.2%	-14.7%	-4.3%
YoY Change	—	—	—	—	+49.3%	+97.3%	+21.4%	-2.3%	-42.5%	-41.8%	-47.3%	+9.2%	+22.2%	+49.6%	+87.7%	-12.0%	+12.7%	-11.4%	-1.1%	+4.3%

Range$4.91B – $13.85B

CAGR+3.2%

Avg YoY Growth+12.2%

Median YoY Growth+6.7%

Current Streak2 quarters decline

Frequently Asked Questions

What is Pfizer's u.s. — revenues:?: Pfizer (PFE) reported u.s. — revenues: of $8.73B in Q1 2026.
How has Pfizer's u.s. — revenues: changed year-over-year?: Pfizer's u.s. — revenues: increased by 4.3% year-over-year, from $8.37B to $8.73B.
What is the long-term trend for Pfizer's u.s. — revenues:?: Over 4 years (2021 to 2025), Pfizer's u.s. — revenues: has grown at a 5.7% compound annual growth rate (CAGR), from $29.75B to $37.08B.